Topical Drug Delivery for Skin Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 January 2026 | Viewed by 25
Special Issue Editor
Special Issue Information
Dear colleagues,
Pharmaceutics is excited to announce a Special Issue on "Topical Drug Delivery for Skin Diseases." Topical drug delivery plays a crucial role in the treatment of skin diseases such as psoriasis, eczema, acne, dermatitis, and skin infections. Localized delivery offers the advantage of targeted action, reduced systemic side effects, and improved patient compliance. However, challenges such as low skin permeability, drug stability, and sustained release remain significant hurdles. Recent advances in formulation technologies, including liposomes, ethosomes, nanostructured lipid carriers, hydrogels, and microneedles, have demonstrated promise in enhancing drug penetration and therapeutic efficacy. This Special Issue aims to explore innovative strategies in the design, optimization, and evaluation of topical drug delivery systems, with a particular focus on overcoming skin barrier challenges, improving drug retention, and enabling controlled release.
We invite researchers and professionals in pharmaceutical sciences to submit their original research and reviews, advancing the science of topical drug delivery for effective and innovative treatments of skin diseases.
Prof. Dr. Rudolf E. Schopf
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- topical drug delivery
- skin diseases
- psoriasis
- eczema
- nanotechnology
- liposomes
- ethosomes
- microneedles
- hydrogels
- controlled release
- dermal penetration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
